Press Releases

New PET imaging tracer helps spot signs of Alzheimer’s disease years before symptoms appear

A new positron emission tomography radiotracer has the potential to spot signs of Alzheimer’s disease years...

FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease

CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co.,...

Cerveau Technologies, Inc. announces Formation of Scientific Advisory Board

Cerveau Technologies, Inc. today announced formation of its Scientific Advisory Board (SAB), comprised of top tier...

Cerveau Scientific Advisory Board Virtual Conference 2020

MK-6240 Users Group Meeting | Webinar #1 by Cerveau Technologies Inc 2020 Virtual Conference with world...

Cerveau Technologies, Inc. Announces Collaboration with University College of London

BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced a research collaboration with University College London (UCL), a leading...

Cerveau Technologies, Inc. Announces Collaboration with Alector, Inc.

BOSTON–(BUSINESS WIRE)–Cerveau Technologies Inc. today announced a licensing agreement with Alector, in which Cerveau will provide...

Enigma Biomedical Group Announces Appointment of Michael Reitermann to Their Board of Directors

TORONTO–(BUSINESS WIRE)–Enigma Biomedical Group (EBG) today announced the appointment of Michael Reitermann to their Board of...

Cerveau Technologies, Inc. Announces Initiation of Japanese Phase I Study

KNOXVILLE, Tennessee--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced that the first healthy volunteer was injected and scanned...

Cerveau Technologies Inc. Signs Research Agreement with Takeda to Provide Novel Tau Imaging Agent

BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda),...